Insulin Price Lawsuit

Insulin has been a life-saving medication for individuals with diabetes since the early 1900s. There have been no major modifications to insulin or its adjunct drugs since their discovery.

Yet the price of insulin has risen dramatically, particularly since the mid-1990s and early 2000s. In the last decade alone, manufacturers have increased the prices of their insulins by over 1,000%.

Insulin, which costs less than $2 to produce, was initially priced at around $20 per drug in the late 1990s. It now carries list prices ranging between $300 and $700 per drug.

For example, Humalog’s insulin brand prices have increased by 1,527% since 1997, while most consumer goods have increased by only 25%.

Plaintiffs say three of the largest pharmaceutical companies in the world, Eli Lilly and Co., Novo Nordisk Inc., and Sanofi-Aventis U.S. LLC, artificially inflated the prices of lifesaving insulin in order to profit at the expense of the health and livelihood of individuals with diabetes or prediabetes across the United States.

Legal actions are underway to address this issue. To date, certain State Attorneys General and some government subdivisions have filed claims against manufacturers and PBMs.

Named Partner Jayne Conroy has been appointed to the Plaintiffs’ Executive Committee of this important litigation against the insulin manufacturers and pharmacy benefit managers.

“This suit seeks to secure accountability against these corporations, ensure the wellbeing of affected individuals in the near and long term, and bring an end to the predatory pricing of insulin,” said Jayne Conroy.

The pending cases have been coordinated as part of a multidistrict litigation pending in Federal District Court in New Jersey in front of Judge Brian Martinotti.

Our lawyers have held key leadership roles in groundbreaking litigation against Purdue Pharma and Abbott Laboratories, alleging 5,000 clients’ addictions to OxyContin were a result of the manufacturers’ fraudulent marketing campaigns that claimed the opiate was not as addictive as alternative drugs.

We have a long track record of holding powerful corporations and drug manufacturers accountable for misleading marketing and wrongdoing.

A few of our results include:

• Over $1.7 billion in settlements from multiple major opioid manufacturers and distributors for Suffolk and Nassau County, as well as the state of New York, its counties, and New York City
• $523 million in settlements by Teva and Anda to pay New York opioid claims
• $34 million in cash and to provide $20 million of the overdose reversal drug Narcan from Teva and Allergan to pay San Francisco
• $4.25 billion to be paid by Teva Pharmaceuticals to New Mexico
• $2.37 billion in settlements to New Mexico by Allergan
• $650.5 million in abatement fees against CVS, Walgreens, and Walmart in Lake and Trumbull counties in Ohio for contributing to the opioid epidemic
• $1.69 billion for clients who suffered serious side effects after taking Yaz/Yasmin birth control medication
• $2.3 billion global settlement for more than 3,500 clients who took the diabetes drug Actos, which allegedly caused bladder cancer and other serious health problems

Our attorneys have effectively invented large-scale, multi-defendant opioid litigation against drug manufacturers and distributors, recovering billions on behalf of individuals, businesses, and municipalities.

Call (855) 264-6270 now or fill out our contact form to find out if we can fight for your community.